Scientific Program
|
Opening Ceremony and Plenary Forum |
|
|
Time: 09:00-12:00, March 10, 2022 |
|
| Moderator | To Be Confirmed Soon |
|
Time |
Speeches and Speakers |
| 09:00-09:30 | Speech Opportunity Available |
| 09:30-10:00 | Title: From Structure-guided Drug Discovery in Academia to Drugs on the Market for Cancer in Astex Pharma Dr. Tom Blundell, Director of Research and Professor Emeritus, University of Cambridge, UK |
| 10:00-10:30 | Title: Directed Gene Delivery Via Targeted Exosomes to Cancer Dr. A. C. Matin, Professor, Stanford University School of Medicine, USA |
| 10:30-11:00 | Title: The Origin of Bladder Cancer Dr. Bogdan Czerniak, Professor, The University of Texas M. D. Anderson Cancer Center, USA |
|
11:00-11:30 |
Title: TBD Dr. Russel J. Reiter, Professor, University of Texas Health Science Center, USA |
| 11:30-12:00 | Speech Opportunity Available |
|
Session 101: Advances in Cancer Cell Biology |
|
|
Time: 13:30-17:10, March 10, 2022 |
|
| Chair | Dr. Claire Wells, Reader in Cancer Cell Biology Head Invasion and Metastasis Research Group FoLSM Associate Dean For Doctoral Studies, King's College London, UK |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Speech Opportunity Available |
| 14:00-14:25 |
Title: The Nuclear Translocation of ERK as a Therapeutic Target for Cancer and Inflammation Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel |
| 14:25-14:50 | Title: TBD Dr. Marika Crohns, University of Tampere, Finland |
| 14:50-15:15 |
Title : Cancer-testis Antigens MAGEA Proteins are Incorporated Into Extracellular Vesicles Released by Cells |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. Severino Rey, President and CEO of Foundation for sciences and research (FORESC), Professor, Albizú University, USA |
| 15:55-16:20 | Title: TBD Dr. Taco Nicilai, UMR CNRS Université du Maine, France |
| 16:20-16:45 | Title: TBD Dr. Raden Danarto, Universitas Gadjah Mada, Dr. Sardjito Hospital, Indonesia |
| 17:45-17:10 | Title: Claudin-1, A New Tumor Suppressor Protein in Triple-Negative Breast Cancer Cells Dr. Marine Lemesle, Université de Lorraine, France |
| Session 201: Artificial Intelligence and Machine Learning in Cancer Diagnosis | |
|
Time: 13:30-17:10, March 10, 2022 |
|
| Chair | Dr. Aniruddha Ganguly, Program Director, National Cancer Institute, USA |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Speech Opportunity Available |
| 14:00-14:25 | Title: TBD Dr. Ramon Simon-Lopez, Medical Director, Immucura, Switzerland |
| 14:25-14:50 | Title: Prostate, Bladder, Kidney or Testis Cancer Dr. Camila Burity, Hospital Municipal Dr. Mário Gatti, Brazil |
| 14:50-15:15 | Title: An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model Dr. Jatinder Kumar, University of Florida, USA |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. G. I. Hagverdiyeva, N.N. Blohin Russian Cancer Research Center, Russia |
| 15:55-16:20 | Title: TBD Dr. Aniruddha Ganguly, Program Director, National Cancer Institute, USA |
| 16:20-16:45 | Title: TBD Dr. Lisa Jacobs, Associate Professor, Johns Hopkins Hospital, USA |
| 17:45-17:10 | Title: Blood Cancer Diagnosis in Laser-Induced Breakdown Spectroscopy Dr. Qi Jianwei, Chinese Academy of Medical Sciences (Institute of Hematology), China |
|
Session 301: New Anti-cancer Drug Discovery, Design, and Optimization |
|
|
Time: 13:30-17:10, March 10, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Speech Opportunity Available |
| 14:00-14:25 | Title : Allosteric Protein Degraders in the Fight Against Cance Dr. Vehary Sakanyan, Professor, University of Nantes, France |
| 14:25-14:50 | Title: TBD Dr. Shraga Shany, Professor, Ben Gurion University, Israel |
| 14:50-15:15 | Title: TBD Dr. Zvi Naor, Professor, Tel Aviv University, Israel |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title : A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer Dr. Giuseppina Sanna, Nuovo Ospedale-Santo Stefano Instituto Toscano Tumori, Italy |
| 15:55-16:20 | Title : Strigolactones: A Plant Phytohormone As Novel Anti-Inflammatory Agents Prof. Jialiang Guo, Foshan University ,China |
| 16:20-16:45 | Title: TBD Dr. Xin Jiang, the University of New South Wales, Australia |
| 17:45-17:10 |
Title: Molecular iodine in chemoresistant cancers Dr. Carmen Aceves, Universidad Nacional Autómona de México, México |
|
Session 401: Gynecologic Cancer |
|
|
Time: 13:30-17:10, March 10, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Speech Opportunity Available |
| 14:00-14:25 | Title: Rehabilitation of Breast Cancer Survivors — Russian Expirience Dr. Inna Apolikhina, Professor, Head of the Department of Aesthetic gynecology and Rehabilitationt the Federal State Budget Institution "National medical research center for obstetrics, Russia |
| 14:25-14:50 | Title: Endometrial Spatio-Temporal Image Correlation (STIC) and Prediction of Outcome Following Assisted Reproductive Treatment Dr. Nick Raine-Fenning, Associate Professor o, University of Nottingham, UK |
| 14:50-15:15 | Title: TBD Dr. Allison Hicks, The Hicks Foundation, USA |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. Liane Deligdisch, Professor of Pathology and Obstetrics-Gynecology, The Mount Sinai Icahn School of Medicine, USA |
| 15:55-16:20 | Title: TBD Dr. Michael von Wolff, Professor, Abteilung für gynäkologische Endokrinologie und Reproduktionsmedizin,Universitäts-Frauenklinik Bern, Switzerland |
| 16:20-16:45 | Title: TBD Dr. Heather Macdonald, Medical Director, Hoag Hospital, USA |
| 17:45-17:10 | Title: Multimodal Therapy of Primary Ovarian Cancer Dr. Michael Friedrich, Professor, Klinik für Frauenheilkunde und Geburtshilfe, Germany |
|
Session 402: Breast Cancer |
|
|
Time: 13:30-17:10, March 10, 2022 |
|
| Chair | Dr. Peiying Yang, Associate Professor, The University of Texas MD Anderson Cancer Center, USA |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title: TBD Dr. Rani Kanthan, Professor, University of Saskatchewan, Saskatoon, Canada |
| 14:00-14:25 | Title: The Prognostic Value of Immunohistochemical Expression of PD1 and PD-L1 on Tumor Cells and Tumor-Infiltrating Stromal Immune Cells in Primary Breast Cancer Dr. Agnes Bankfalvi, Professor, University Clinic of Essen, Germany |
| 14:25-14:50 | Title: TBD Dr. Pierre Bénédict, Directtor, Institut de radiologie, Switzerland |
| 14:50-15:15 |
Title: Supporting and Empowering Breast Cancer Patients through their Trajectory – the Israeli Experience |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. Ora Rosengarten, Shaare Zedek Medical Center, Israel |
| 15:55-16:20 | Title : Sugar and Breast Cancer: What we Have Learned Dr. Peiying Yang, Associate Professor, The University of Texas MD Anderson Cancer Center, USA |
| 16:20-16:45 | Title : Ion Beam Analysis of Trace Elements in Cancerous Breast Tissues Dr. David O Olaiya, Obafemi Awolowo University, Nigeria |
| 17:45-17:10 | Title: Female Students’ Knowledge, Beliefs, Attitude and Practice of Breast Self-Examination in a University in the Western Cape Dr. Mavis Bobie Ansah, Oncology Nurse Specialist, tKomfo Anokye Teaching Hospital, Ghana |
|
Session 501: Molecular Targets and Cancer Therapeutics |
|
|
Time: 13:30-17:10, March 10, 2022 |
|
| Chair | Dr. Vladimir Lazar, Chief Scientific and Operating Officer, WIN Consortium, France |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title: TBD Dr. James A. Bonner, Professor, University of Alabama-Birmingham, USA |
| 14:00-14:25 | Title: TBD Dr. Dorit Avni, Sphingolipids, MIGAL - Galilee Research Institute, Israel |
| 14:25-14:50 | Title: Novel Targeted Therapies For Lymphoma Dr. Lapo Alinari, The Ohio State University Medical Center, USA |
| 14:50-15:15 | Speech Opportunity Available |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. Vladimir Lazar, Chief Scientific and Operating Officer, WIN Consortium, France |
| 15:55-16:20 | Title: Role of CD47 in Hematological Malignancies Dr. AijunLiu, Vice leader, Beijing Chaoyang Hospital affiliated to Capital Medical University, China |
| 16:20-16:45 | Title: TBD Dr. Qiong Ma, Fourth Military Medical University, China |
| 17:45-17:10 | Speech Opportunity Available |
|
Session 601: Cancer Rehabilitation, Cancer Nursing and Care |
|
|
Time: 13:30-17:10, March 10, 2022 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title : Fellowship Program to Develop the Next Generation of Oncology Nurses Dr. Frederick C. Flynn, Founder/Sponsor, Susan D. Flynn Oncology Nursing Development Program, Inc, USA |
| 14:00-14:25 | Title : Dermocosmetic Management of the Skin Adverse Effects in Oncology Patients Dr. Athanasia Varvaresou, Professor, University of West Attica, Greece |
| 14:25-14:50 | Title: When Autoimmunity Fuels Cancer Immunosurveillance in the Biliary Tract Dr. Jonathan Pol, 5Gustave Roussy Comprehensive Cancer Institute, France |
| 14:50-15:15 | Title: TBD Dr. Penny Daugherty, Oncology Nurse Navigator, Northside Hospital Cancer Institute, USA |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 |
Title: Improving Cancer MDT performance in Western Sydney – Three Years’ Experience Dr. Lynleigh Evans, Senior Medical Advisor, Western Sydney Local Health District, Australia |
| 15:55-16:20 |
Title : Team Resilience at Work in Oncology: A Multi-Component Intervention in Québec (Canada) |
| 16:20-16:45 | Title: TBD Dr. Aiat Morsy, lecturer, Assiut University, Egypt |
| 17:45-17:10 | Speech Opportunity Available |
Hosting Organization
Official Travel Agency
Media
Partners
Contact Us
Add: Life Science Innovation Center BLD 3-2, 43 Torch Road,
High Tech Park, Dalian, LN 116023, China
© 2003-2022 All rights reserved by BIT Congress
